EVE Health Group Ltd
EVE Health Group Limited, together with its subsidiaries, engages in the retail and distribution of health and wellness products. The company offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. It also sells its products through online store. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003… Read more
EVE Health Group Ltd (EVEDA) - Net Assets
Latest net assets as of June 2024: AU$1.22 Million AUD
Based on the latest financial reports, EVE Health Group Ltd (EVEDA) has net assets worth AU$1.22 Million AUD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$2.52 Million) and total liabilities (AU$1.30 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$1.22 Million |
| % of Total Assets | 48.51% |
| Annual Growth Rate | -50.65% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 12.46 |
EVE Health Group Ltd - Net Assets Trend (2021–2024)
This chart illustrates how EVE Health Group Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EVE Health Group Ltd (2021–2024)
The table below shows the annual net assets of EVE Health Group Ltd from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | AU$1.22 Million | -60.83% |
| 2023-06-30 | AU$3.12 Million | -54.93% |
| 2022-06-30 | AU$6.93 Million | -31.95% |
| 2021-06-30 | AU$10.19 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to EVE Health Group Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1103914000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | AU$36.03 Million | 2943.51% |
| Total Equity | AU$1.22 Million | 100.00% |
EVE Health Group Ltd Competitors by Market Cap
The table below lists competitors of EVE Health Group Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SCIENCE IN SPORT LS-10
F:8D9
|
$68.33 Million |
|
7712
TWO:7712
|
$68.34 Million |
|
The ONE Enterprise Public Company Limited
BK:ONEE-R
|
$68.36 Million |
|
MagnaChip Semiconductor
NYSE:MX
|
$68.37 Million |
|
Poongwon Precision Co. Ltd.
KQ:371950
|
$68.29 Million |
|
Hotel Mandarine Regency Tbk PT
JK:HOME
|
$68.27 Million |
|
Erbud SA
WAR:ERB
|
$68.22 Million |
|
Li-FT Power Ltd
PINK:LIFFF
|
$68.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EVE Health Group Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,124,980 to 1,223,992, a change of -1,900,988 (-60.8%).
- Net loss of 1,900,992 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-1.90 Million | -155.31% |
| Other Changes | AU$4.00 | +0.0% |
| Total Change | AU$- | -60.83% |
Book Value vs Market Value Analysis
This analysis compares EVE Health Group Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 172.37x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 18.11x to 172.37x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-06-30 | AU$0.00 | AU$0.04 | x |
| 2022-06-30 | AU$0.00 | AU$0.04 | x |
| 2023-06-30 | AU$0.00 | AU$0.04 | x |
| 2024-06-30 | AU$0.00 | AU$0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EVE Health Group Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -155.31%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -89.09%
- • Asset Turnover: 0.85x
- • Equity Multiplier: 2.06x
- Recent ROE (-155.31%) is below the historical average (-99.46%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -35.64% | -129.62% | 0.23x | 1.17x | AU$-4.65 Million |
| 2022 | -77.48% | -224.71% | 0.30x | 1.16x | AU$-6.07 Million |
| 2023 | -129.41% | -173.51% | 0.56x | 1.32x | AU$-4.36 Million |
| 2024 | -155.31% | -89.09% | 0.85x | 2.06x | AU$-2.02 Million |
Industry Comparison
This section compares EVE Health Group Ltd's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $97,041,172
- Average return on equity (ROE) among peers: -109.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EVE Health Group Ltd (EVEDA) | AU$1.22 Million | -35.64% | 1.06x | $68.31 Million |
| Australian Dairy Nutritionals Ltd (AHF) | $26.73 Million | -27.52% | 0.14x | $7.62 Million |
| Beston Global Food Company Ltd (BFC) | $113.64 Million | -1.66% | 0.03x | $3.27 Million |
| Biome Australia Ltd (BIO) | $6.53 Million | -69.59% | 0.26x | $32.26 Million |
| Bioxyne Ltd (BXN) | $1.18 Million | -369.02% | 1.02x | $21.29 Million |
| Cobram Estate Olives Ltd (CBO) | $321.75 Million | 5.76% | 1.17x | $650.87 Million |
| The Calmer Co International Ltd (CCO) | $1.38 Million | -272.44% | 1.13x | $2.07 Million |
| Forbidden Foods Ltd (FFF) | $875.19K | -265.77% | 1.78x | $1.49 Million |
| Fonterra Shareholders Fund (FSF) | $388.00 Million | 0.00% | 0.00x | $26.81K |
| Health and Plant Protein Group Ltd (HPP) | $13.30 Million | 10.47% | 0.52x | $448.86K |